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Novel coronavirus disease or 2019 coronavirus disease (COVID-19) is caused by the 2019-severe acute respiratory syndrome coronavirus 2 (2019-SARS-CoV2), and typically manifests with systemic symptoms like fever and myalgia as well as respiratory symptoms including dry cough, dyspnoea and anosmia \[[@bib1]\]. Reports suggest that lineage B β-coronaviruses that are highly pathogenic to humans such as the 2002-SARS-CoV1 and 2019-SARS-CoV2 can affect the liver and induce acute hepatitis \[[@bib2],[@bib1]\]. Herein, we report the cases of two patients who developed COVID-19 presenting as an acute acalculous cholecystitis.

The first case was an 84-year-old female patient who presented to our emergency department with symptoms and signs of urinary tract infection and fever (38.5 ˚C) for 24 hours. Sepsis due to pyelonephritis was the initial diagnosis after a pathological urinalysis and positive urine culture. Blood tests revealed a slight cytolysis. Ceftriaxone was initiated alongside supportive care. On day 3, a right upper quadrant pain emerged, and on day 5, a positive Murphy sign was detected along with an increase in CRP, reaching 249.3 mg/l (Table S1). Ultrasonography revealed increased thickening of the gallbladder wall as well as peri-vesicular fluid. A thoraco-abdominal CT scan ruled out gallbladder perforation and showed a normal pulmonary parenchyma ([Figure 1](#fig1){ref-type="fig"} A). Metronidazole was added to the treatment and the patient underwent a laparoscopic cholecystectomy on day 8.Figure 1Radiological findings and SARS-CoV2 q-rt-PCR of the gallbladder of patient one

After extubation, the patient developed respiratory symptoms evolving into acute respiratory distress syndrome. Nasopharyngeal swabs confirmed the presence of 2019-SARS-CoV2 RNA. The patient was transferred to the intensive care unit and passed away at postoperative day 5 from multi organ failure. Histological analysis of the gallbladder did not demonstrate any inflammation but quantitative reverse transcriptase polymerase chain reaction (q-rt-PCR) of gallbladder revealed the presence of 2019-SARS-CoV2 in all three sampled regions of the gallbladder wall ([Figure 1](#fig1){ref-type="fig"}B-C).

The second case concerned an 83-year-old man on dialysis for end-stage renal disease with type 2 diabetes, arterial hypertension and moderate aortic stenosis who was admitted for fever (38.3° C). No abdominal or respiratory symptoms were identified upon admission, and chest x-ray was normal. On day 5, the patient developed right upper quadrant pain with a positive Murphy sign, degradation of his inflammatory markers (CRP 209.9 mg/l, white blood cells (WBC) 19.5 G/l \[Table S2\]) and hepatic enzymes increase. Abdominal ultrasonography revealed a 4mm thickening of the gallbladder wall, presence of peri-vesicular liquid, absence of gallstones and a radiologic Murphy sign. Conservative management with Ceftriaxone and Metronidazole therapy was initiated and led to a slow recovery. On day 6, the patient presented respiratory symptoms and a 2019-SARS-CoV infection was confirmed.

SARS coronaviruses have a tropism to the lungs but also to the liver \[[@bib1]\]. Indeed, the intracellular entry of the virus occurs through interaction with the angiotensin-converting enzyme 2 receptor (ACE2) which is present in several tissues, including lungs and liver \[[@bib1]\]. In 2002-SARS-CoV autopsies, liver tissue exhibited different patterns of hepatocyte injuries, and viral RNA was found inside hepatocytes \[[@bib3]\]. Both 2002-SARS-CoV and 2019-SARS-CoV-2 are characterized by cytolysis with mild elevation of AST and ALT levels \[[@bib4],[@bib5]\]. Moreover, angiotensin-converting enzyme 2 receptor levels are higher in bile duct cells and Xu *et al.* suggested that liver injury induced by highly pathogenic SARS coronaviruses may be due to a direct harm to bile duct cells \[[@bib5]\]. COVID-19 related acalculous cholecystitis was presented in few case reports and managed with surgery or gallbladder percutaneous drainage \[[@bib6],[@bib7]\]. Ying et al. performed rt-PCR of the bile after percutaneous drainage of the gallbladder in a patient with sludge and acute cholecystitis but did not detect 2019-SARS-CoV2 \[[@bib8]\]. Gallbladder epithelial cells are very similar to bile duct cells, express ACE2 and could be a target of the 2019-SARS-CoV2 \[[@bib9]\]. rt-PCR of the formaldehyde fixed gallbladder of the first patient did not detect SARS-CoV2-RNA with appropriate positive and negative controls (data not shown) but Q-rt-PCR testing confirmed the presence of the virus indicating that 2019-SARS-CoV2 was specifically present in the gallbladder. However, significance of this finding to COVID-19 pathogenesis remains to be determined.

COVID-19 can present uniquely with digestive symptoms, without any respiratory manifestations, a longer time from onset to admission, and a worse prognosis \[[@bib10]\]. The two cases presented herein exhibited an evolving clinical picture of acalculous cholecystitis with radiological pattern of progressive wall thickening, perivesicular fluid and a positive radiological and clinical Murphy sign. Digestive symptoms preceded the classic respiratory manifestation of COVID-19. Hepatic COVID-19 manifestation in those patients might explain both the clinical picture that was induced by hepatitis and the radiological pattern of cholecystitis.

2019-SARS-CoV2 infection can mimic acalculous acute cholecystitis and viral RNA detection into the gallbladder indicates direct vesicular involvement, while the exact pathogenesis remains to be elucidated. Differential diagnosis can be challenging in this case and rapid testing for 2019-SARS-CoV2, and potentially conservative management might make a difference in patients' outcomes.

Abdominal CT scan of the first patient showed signs of cholecystitis with peri-cholecystic fluid (A). A Q-rt-PCR of patient one specimen was performed to assess the presence of SARS-CoV2 in gallbladder. Standard protocols were used with the following primers: forward ACAGGTACGTTAATAGTTAATAGCGT reverse ATATTGCAGCAGTACGCACACA and a fluorescently labelled probe FAM-ACACTAGCCATCCTTACTGCGCTTCG-BBQ (complete protocol in supplementals) The three samples from the gallbladder: A1 (blue), A2 (grey) and A3 (orange) were all positive for the presence of SARS-CoV2 (experiment repeated 3 times with two different extractions of RNA) (B). The RNA control was consistently positive (B1 \[blue\], B2 \[blue\], B3 \[grey\]) (C).
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